# HAVN Life Sciences Inc. (HAVLF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HAVLF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ -12.5K | $ -717.6K | $ 300.0K | N/A | $ 837.8K |
| 2022 | $ 667.4K | $ -21.39M | $ -4.68M | $ 310.0K | $ 938.6K |
| 2021 | $ 42.3K | $ -37.70M | $ -14.77M | $ 424.1K | $ 13.46M |
| 2020 | $ 0 | $ -7.44M | $ -3.07M | $ 0 | $ 5.39M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.65 |
| Current Ratio | 2.68 |

## Other views

- [Metrics](https://sponda.capital/en/HAVLF.md)
- [Charts](https://sponda.capital/en/HAVLF/charts.md)
- [Compare](https://sponda.capital/en/HAVLF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.